About Technopath Clinical Diagnostics
Technopath Clinical Diagnostics is a global leader in the development and manufacture of total quality control (QC) solutions for clinical laboratories. We launched the IVD industry’s first truly consolidated Immunochemistry Quality Control (QC) materials. Consolidating multiple tests into one QC product enables clinical laboratories to significantly improve the efficiency and cost effectiveness of QC processes. Our IAMQC® software platform automates the handling and management of QC data, while facilitating laboratory accreditation requirements. Our software solutions provide clinical laboratories with significant cost and time savings, whilst delivering higher confidence in analytical testing methods. IAMQC software products are practical, graphical, userdefinable and easy to use. Today, our QC and software products are used by leading laboratories in over 120 countries globally.
Founded in 2004, we are an Irish company with a proven track record of achievement driven by our customer focus. We operate from a state of the art manufacturing facility using an extensive team of highly skilled biochemists, QC scientists and production assistants. Our business has grown over the years thanks to our network of distributors as well as long term global partnerships with large IVD platform manufacturers including Abbott Laboratories, Radiometer and Beckman Coulter.
In 2017, we established a full time presence in the USA through Technopath Clinical Diagnostics USA, a joint venture between Technopath Clinical Diagnostics and New York State’s largest health care provider Northwell Health, with a fully operations distribution centre situated in Long Island, New York.
In 2019, Technopath partnered with NRL, a not-for-profit, scientific organisation with extensive experience and knowledge of testing for infectious diseases, to release a new range of QC materials for infectious diseases called Multichem® ID in association with NRL’s QConnect™ program.
The proprietary manufacturing processes we have developed positions Technopath at the forefront in matrix stability and consolidation matrices for clinical diagnostics Quality Control products. We have a distinct product offering with excellent track record of innovation. Compared with competitor products, Multichem® offers fewer vials, creating savings across laboratory processes and in turn, increasing efficiencies. Consolidation enables clinical laboratories to significantly reduce handling requirements, reclaim storage space and minimise waste, leading to a more efficient quality control process. Technopath’s core product offering is focused on making the QC process simpler and more efficient for laboratories and more accurate and precise for patients by designing products that are targeted at clinical decision points and consolidate the number of quality control materials required by the laboratory while automating the reporting and data management process. Technopath has focussed on creating a lean product design that ensures end-users minimise their carbon footprint.
Every day we are committed to delivering high quality, safe and effective clinical diagnostic products to achieve maximum customer satisfaction; by complying with the appropriate regulatory requirements supported by our Quality Management System.
Technopath Clinical Diagnostics is ISO 13485 certified and has successfully achieved international regulatory market approvals for example:
- IVD 98/79/EC
- Europe CE Mark
- US FDA 510K
- Health Canada
- China NMPA
- Brazil ANVISA
- Australia TGA